Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2002 4
2003 1
2004 1
2005 2
2006 3
2009 1
2010 3
2011 1
2013 2
2014 1
2016 1
2017 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Tamoxifen and pregnancy.
Barthelmes L, Gateley CA. Barthelmes L, et al. Breast. 2004 Dec;13(6):446-51. doi: 10.1016/j.breast.2004.08.007. Breast. 2004. PMID: 15563850 Review.
Pregnancy and breast cancer.
Barthelmes L, Davidson LA, Gaffney C, Gateley CA. Barthelmes L, et al. BMJ. 2005 Jun 11;330(7504):1375-8. doi: 10.1136/bmj.330.7504.1375. BMJ. 2005. PMID: 15947401 Free PMC article. Review. No abstract available.
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
Coombes RC, Tovey H, Kilburn L, Mansi J, Palmieri C, Bartlett J, Hicks J, Makris A, Evans A, Loibl S, Denkert C, Murray E, Grieve R, Coleman R, Borley A, Schmidt M, Rautenberg B, Kunze CA, Rhein U, Mehta K, Mousa K, Dibble T, Lu XL, von Minckwitz G, Bliss JM; Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators. Coombes RC, et al. JAMA Oncol. 2021 Sep 1;7(9):1291-1301. doi: 10.1001/jamaoncol.2021.2193. JAMA Oncol. 2021. PMID: 34264305 Free PMC article. Clinical Trial.
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Bergamino MA, López-Knowles E, Morani G, Tovey H, Kilburn L, Schuster EF, Alataki A, Hills M, Xiao H, Holcombe C, Skene A, Robertson JF, Smith IE, Bliss JM, Dowsett M, Cheang MCU; POETIC investigators. Bergamino MA, et al. EBioMedicine. 2022 Sep;83:104205. doi: 10.1016/j.ebiom.2022.104205. Epub 2022 Aug 16. EBioMedicine. 2022. PMID: 35985932 Free PMC article.
Pneumomastia: a rare cause of breast swelling.
Kipling M, Christou C, Barthelmes L. Kipling M, et al. Among authors: barthelmes l. Breast Care (Basel). 2013 Jun;8(3):218-9. doi: 10.1159/000352098. Breast Care (Basel). 2013. PMID: 24415974 Free PMC article.
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer.
Holt S, Verrill M, Pettit L, Rigg A, Hickish T, Archer C, Dent J, Dillon M, Nathan M, Barthelmes L, Rehman S, Sharaiha Y, Innis P, Sai-Giridhar P, Khawaja S. Holt S, et al. Among authors: barthelmes l. Br J Cancer. 2024 Apr;130(7):1149-1156. doi: 10.1038/s41416-024-02588-9. Epub 2024 Feb 2. Br J Cancer. 2024. PMID: 38308000 Free PMC article.
23 results